COVID-19 vaccine for kids under 5 delayed as Pfizer extends trial

Feb 11, 2022

Also, protection against serious Omicron illness drops by 4 months after a third dose but is still high, new data show.

Stephanie Soucheray | News Reporter | CIDRAP NewsFeb 11, 2022Also, protection against serious Omicron illness drops by 4 months after a third dose but is still high, new data show.Read More

Leave a Reply

Your email address will not be published.